Reports
The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.
MEDI-NEWS - Based on Lancet 2013;381(9869):825-35.
Invasive Meningococcal Disease in Infants: Immunogenicity and Safety of a Novel Multi-Component Serogroup B Vaccine
Serogroup B is now the dominant cause of invasive meningococcal disease (IMD) in Canada where it disproportionally affects infants. This underscores the importance of having an effective vaccine for this vulnerable age group. A...
PRIORITY PRESS - 8th World Congress of Melanoma
New Advances in the Treatment of Basal Cell Carcinoma: Targeting the Hedgehog Signaling Pathway
Hamburg, Germany / July 17-20, 2013
Hamburg - Until recently, treatment options for advanced basal cell carcinoma (BCC) were limited and suboptimal. Research into novel therapeutic targets identified mutations in the hedgehog signaling pathway as a possible cause of new...
PRIORITY PRESS - XXIV Congress of the International Society on Thrombosis and Haemostasis (ISTH)/ 59th Annual Scientific and Standardization Committee (SSC) Meeting
Potential for Advances in the Treatment of Hemophilia A
Amsterdam, The Netherlands / June 29-July 4, 2013
Amsterdam - Current treatment for patients with hemophilia A, the most common hereditary coagulation disorder, involves intravenous injection of human factor VIII given on demand in response to a bleeding event or as a prophylactic therapy....
MEDICAL FRONTIERS - XXIV Congress of the International Society of Thrombosis and Haemostasis (ISTH)/ 59th Annual SSC Meeting
New Horizons in the Treatment of Hemophilia A and B
Amsterdam, The Netherlands / June 29–July 4, 2013
Amsterdam - Current treatment for patients with hemophilia involves intravenous injection of clotting factor concentrate either given on demand in response to a bleeding event or as prophylactic therapy. Since the introduction of...
ABSTRACTS in PERSPECTIVE - Based on presentations from the 73rd Scientific Sessions of the American Diabetes Association (ADA)
Maturing Clinical Experience with SGLT2 Inhibitors Is Clarifying Clinical Applications
Chicago, Illinois / June 21-25, 2013
EDITORIAL OVERVIEW: Philip A. McFarlane, MD, PhD, FRCPC Division of NephrologySt. Michael’s HospitalUniversity of TorontoToronto, Ontario Jean-Francois Yale, MD, FRCPCMcGill University Health CentreMcGill UniversityMontreal,...
PRIORITY PRESS - 73rd Scientific Sessions of the American Diabetes Association (ADA)
Clarity Grows on the Role of SGLT2 Inhibitors in Routine Control of Type 2 Diabetes
Chicago, Illinois / June 21-25, 2013
Chicago - The order in which oral agents are employed to control type 2 diabetes mellitus (T2DM) is under consideration as a result of the introduction of sodium glucose co-transporter 2 (SGLT2) inhibitors, based on clinical trial results...
PRIORITY PRESS - 73rd Scientific Sessions of the American Diabetes Association (ADA)
New Antidiabetic Medications Yield Flatter PK, More Predictable Blood Glucose Levels than Standards
Chicago, Illinois / June 21-25, 2013
Chicago - New therapeutic options for insulin-dependent diabetes are inching closer to the ideal of predictable blood glucose control over each 24-hour dosing period, according to large trial data presented at the ADA. Relative to the...
PRIORITY PRESS - International Conference of the American Thoracic Society
Updates in the Treatment of Chronic Thromboembolic Pulmonary and Pulmonary Arterial Hypertension
Philadelphia, Pennsylvania / May 17-22, 2013
Philadelphia - Currently, the gold standard for chronic thromboembolic pulmonary hypertension (CTEPH) is pulmonary endarterectomy (PEA) but when patients are deemed inoperable or when symptoms persist or recur following PEA, new medical...
PRIORITY PRESS - Primary Care Today 2013
Update on Benign Prostatic Hyperplasia in Primary Care
Toronto, Ontario / May 9-11, 2013
Toronto - Lower urinary tract symptoms (LUTS) in older males are a common clinical problem and are often secondary to the development of benign prostatic hyperplasia (BPH). Treatment goals include a reduction in daytime frequency, hesitancy...